Old Web
English
Sign In
Acemap
>
Paper
>
Galectin 3 as a new therapeutic target for fibrosis and metabolic disorders in type 2 diabetes
Galectin 3 as a new therapeutic target for fibrosis and metabolic disorders in type 2 diabetes
2021
D. Khelifi
Ibtissem Ben Nacef
Kahena Bouzid
Imen Rojbi
Youssef Lakhoua
Nadia Mchirgui
Fethi Ben Hamida
Karima Khiari
Keywords:
Galectin-3
Bioinformatics
Type 2 diabetes
Text mining
Medicine
Fibrosis
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]